APA (7th ed.) Citation

A, K., A, M., RR, H., R, E., A, E. T., MR, G., . . . MA, A. (2021). Immunogenicity and Safety of an Inactivated SARS-CoV-2 Vaccine: Preclinical Studies. Vaccines, 9(3), . https://doi.org/10.3390/vaccines9030214

Chicago Style (17th ed.) Citation

A, Kandeil, et al. "Immunogenicity and Safety of an Inactivated SARS-CoV-2 Vaccine: Preclinical Studies." Vaccines 9, no. 3 (2021). https://doi.org/10.3390/vaccines9030214.

MLA (9th ed.) Citation

A, Kandeil, et al. "Immunogenicity and Safety of an Inactivated SARS-CoV-2 Vaccine: Preclinical Studies." Vaccines, vol. 9, no. 3, 2021, https://doi.org/10.3390/vaccines9030214.